These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37489264)

  • 1. Cure rate models for heterogeneous competing causes.
    Brandão M; Leão J; Gallardo DI; Bourguignon M
    Stat Methods Med Res; 2023 Sep; 32(9):1823-1841. PubMed ID: 37489264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A general class of promotion time cure rate models with a new biological interpretation.
    Gómez YM; Gallardo DI; Bourguignon M; Bertolli E; Calsavara VF
    Lifetime Data Anal; 2023 Jan; 29(1):66-86. PubMed ID: 36114312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the use of the modified power series family of distributions in a cure rate model context.
    Gallardo DI; Gómez YM; Gómez HW; de Castro M
    Stat Methods Med Res; 2020 Jul; 29(7):1831-1845. PubMed ID: 31559906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expectation maximization-based likelihood inference for flexible cure rate models with Weibull lifetimes.
    Balakrishnan N; Pal S
    Stat Methods Med Res; 2016 Aug; 25(4):1535-63. PubMed ID: 23740876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new cure rate model with flexible competing causes with applications to melanoma and transplantation data.
    Leão J; Bourguignon M; Gallardo DI; Rocha R; Tomazella V
    Stat Med; 2020 Oct; 39(24):3272-3284. PubMed ID: 32716081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Likelihood inference for COM-Poisson cure rate model with interval-censored data and Weibull lifetimes.
    Pal S; Balakrishnan N
    Stat Methods Med Res; 2017 Oct; 26(5):2093-2113. PubMed ID: 28656795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penalized likelihood estimation of a mixture cure Cox model with partly interval censoring-An application to thin melanoma.
    Webb A; Ma J; Lô SN
    Stat Med; 2022 Jul; 41(17):3260-3280. PubMed ID: 35474515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
    Leão J; Leiva V; Saulo H; Tomazella V
    Stat Med; 2018 Dec; 37(29):4421-4440. PubMed ID: 30109718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cure rate survival model under a hybrid latent activation scheme.
    Borges P; Rodrigues J; Louzada F; Balakrishnan N
    Stat Methods Med Res; 2016 Apr; 25(2):838-56. PubMed ID: 23264557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vertical modeling: analysis of competing risks data with a cure fraction.
    Nicolaie MA; Taylor JMG; Legrand C
    Lifetime Data Anal; 2019 Jan; 25(1):1-25. PubMed ID: 29388073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term frailty modeling using a non-proportional hazards model: Application with a melanoma dataset.
    Calsavara VF; Milani EA; Bertolli E; Tomazella V
    Stat Methods Med Res; 2020 Aug; 29(8):2100-2118. PubMed ID: 31691640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proportional hazards under Conway-Maxwell-Poisson cure rate model and associated inference.
    Balakrishnan N; Barui S; Milienos FS
    Stat Methods Med Res; 2017 Oct; 26(5):2055-2077. PubMed ID: 28523958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation method of the semiparametric mixture cure gamma frailty model.
    Peng Y; Zhang J
    Stat Med; 2008 Nov; 27(25):5177-94. PubMed ID: 18613271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On a class of non-linear transformation cure rate models.
    Balakrishnan N; Milienos FS
    Biom J; 2020 Sep; 62(5):1208-1222. PubMed ID: 32175632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the estimation of interval censored destructive negative binomial cure model.
    Treszoks J; Pal S
    Stat Med; 2023 Dec; 42(28):5113-5134. PubMed ID: 37706586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On a reparameterization of a flexible family of cure models.
    Milienos FS
    Stat Med; 2022 Sep; 41(21):4091-4111. PubMed ID: 35716033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Firth adjusted score function for monotone likelihood in the mixture cure fraction model.
    Almeida FM; Colosimo EA; Mayrink VD
    Lifetime Data Anal; 2021 Jan; 27(1):131-155. PubMed ID: 33184683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplified stochastic EM algorithm for cure rate model with negative binomial competing risks: An application to breast cancer data.
    Pal S
    Stat Med; 2021 Dec; 40(28):6387-6409. PubMed ID: 34783093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expectation Maximization Algorithm for Box-Cox Transformation Cure Rate Model and Assessment of Model Misspecification Under Weibull Lifetimes.
    Pal S; Balakrishnan N
    IEEE J Biomed Health Inform; 2018 May; 22(3):926-934. PubMed ID: 28534799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.